Dioseve

Dioseve is a biotech company in Tokyo, Japan, founded in 2021. It has raised $16.7M across 2 rounds, most recently a $9.7M Venture Round in June 2026.

Providing novel possibilities for all lives.

Headquarters
Tokyo
Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$16.7M
Last Round
$9.7M Venture RoundJun 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Dioseve is a Tokyo-based fertility biotech developing iPS cell-derived ovarian support technologies to improve IVF treatment outcomes. The company uses proprietary differentiation technology to induce oocytes and ovarian somatic cells from iPS cells at high efficiency, targeting age-related fertility decline. Dioseve secured JPY 1.45 billion in June 2026 and counts SHIONOGI CVC among its investors.

Summary

It lists 1–10 employees. It has raised $16.7M in total across 2 rounds, most recently a $9.7M Venture Round in Jun 2026. Investors include Archetype, DG Daiwa Ventures and Miraidoor.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundJun 2026
$9.7M

Sign up to see all 2 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dioseve on Indexed.vc
<a href="https://indexed.vc/companies/dioseve"><img src="https://indexed.vc/api/badge/company/dioseve" alt="Dioseve on Indexed.vc" width="260" height="76" /></a>